- Home
- ACLX vs KFY Comparison
ACLX vs KFY Comparison
Compare ACLX & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACLX | KFY |
|---|---|---|
| Founded | 2015 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | 2022 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ACLX | KFY |
|---|---|---|
| Price | $68.61 | $61.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $113.75 | $78.00 |
| AVG Volume (30 Days) | ★ 868.4K | 486.5K |
| Earning Date | 02-27-2026 | 03-10-2026 |
| Dividend Yield | N/A | ★ 3.14% |
| EPS Growth | N/A | ★ 5.12 |
| EPS | N/A | ★ 4.91 |
| Revenue | $35,898,000.00 | ★ $2,811,089,000.00 |
| Revenue This Year | N/A | $5.60 |
| Revenue Next Year | $309.32 | $4.16 |
| P/E Ratio | ★ N/A | $12.47 |
| Revenue Growth | N/A | ★ 3.78 |
| 52 Week Low | $47.86 | $59.23 |
| 52 Week High | $94.07 | $78.50 |
Technical Indicators
Market Signals| Indicator | ACLX | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 55.39 | 34.28 |
| Support Level | $66.12 | $60.16 |
| Resistance Level | $70.34 | $68.31 |
| Average True Range (ATR) | 2.60 | 2.19 |
| MACD | 0.20 | -0.85 |
| Stochastic Oscillator | 83.43 | 6.40 |
Price Performance
Historical ComparisonAbout ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.